Inhibitors of HIV-1 reverse transcriptase and protease as chemotherapeutics for AIDS
Mitsuya, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 49(9): 2062-2069
1991
ISSN/ISBN: 0047-1852 PMID: 1720470 Document Number: 385550
Document emailed within 1 workday
Related Documents
Choi, J.-y.; Kwon, O.-K.; Choi, S.Y.; Park, Y.K.; Kim, S.S. 2011: Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 50(1): 19-25Engchanil, C.; Kosalaraksa, P.; Lulitanond, V.; Lumbiganon, P.; Chantratita, W. 2006: Multi-drug resistant HIV-1 reverse transcriptase genotype in children treated with dual nucleoside reverse transcriptase inhibitors (NRTIs) Journal of the Medical Association of Thailand 89(10): 1713-1720
Hamilton, C.-L.C.; Eyzaguirre, L.M.; Amarakoon, I.I.; Figueroa, P.; Duncan, J.; Carr, J.K.; Roye, M.E. 2012: Analysis of protease and reverse transcriptase genes of HIV for antiretroviral drug resistance in Jamaican adults Aids Research and Human Retroviruses 28(8): 923-927
Kantor, R.; Zijenah, L.S.; Shafer, R.W.; Mutetwa, S.; Johnston, E.; Lloyd, R.; von Lieven, A.; Israelski, D.; Katzenstein, D.A. 2002: HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy Aids Research and Human Retroviruses 18(18): 1407-1413
Brzezińska, E.; Glinka, R. 2002: Search for new non-nucleoside inhibitors of HIV-1 reverse transcriptase (HIV-1 RT) Acta Poloniae Pharmaceutica 59(5): 379-386
Kraevskiĭ, A.A.; Galegov, G.A. 1992: Reverse transcriptase inhibitors and the therapy of HIV infection Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1992(11-12): 3-6
2000: Non-nucleoside reverse transcriptase inhibitors. First line therapy MMW Fortschritte der Medizin 142(3 Suppl): 34-35
Fokam, J.; Salpini, R.; Santoro, M.M.; Cento, V.; D'Arrigo, R.; Gori, C.; Perno, C.F.; Colizzi, V.; Nanfack, A.; Gwom, L.C.; Cappelli, G.; Takou, D. 2011: Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon Archives of Virology 156(7): 1235-1243
Lafeuillade, A.; Poggi, C.; Djediouane, A.; Chollet, L.; Profizi, N.; Sayada, C. 1997: A pilot study of a combination of three reverse transcriptase inhibitors in HIV-1 infection Antiviral Therapy 2(4): 219-227
Wainberg, M.A.; Sawyer, J.P.C.; Montaner, J.S.G.; Murphy, R.L.; Kuritzkes, D.R.; Raffi, F. 2005: Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection Antiviral Therapy 10(1): 13-28
Tarby, C.M. 2004: Recent advances in the development of next generation non-nucleoside reverse transcriptase inhibitors Current Topics in Medicinal Chemistry 4(10): 1045-1057
Selimova, L.M.; Serebrovskaia, L.V.; Ivanova, L.A.; Nosik, D.N. 2010: CD4+ and CD8+ T-lymphocyte counts in human immunodeficiency virus type 1 subtype A-infected patients carrying mutations V77i in protease and/or A62V in reverse transcriptase Voprosy Virusologii 55(2): 22-26
Kantor, R.; Katzenstein, D. 2003: Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution Aids Reviews 5(1): 25-35
Modi, M.; Goel, T.; Das, T.; Malik, S.; Suri, S.; Rawat, A.K.S.; Srivastava, S.K.; Tuli, R.; Malhotra, S.; Gupta, S.K. 2013: Ellagic acid and gallic acid from Lagerstroemia speciosa L. inhibit HIV-1 infection through inhibition of HIV-1 protease and reverse transcriptase activity Indian Journal of Medical Research 137(3): 540-548
Antinori, A.; Zaccarelli, M.; Cingolani, A.; Forbici, F.; Rizzo, M.G.; Trotta, M.P.; Di Giambenedetto, S.; Narciso, P.; Ammassari, A.; Girardi, E.; De Luca, A.; Perno, C.F. 2002: Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure Aids Research and Human Retroviruses 18(12): 835-838
Stankov, M.V.; Lücke, T.; Das, A.M.; Schmidt, R.E.; Behrens, G.M.N. 2007: Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors Antiviral Therapy 12(2): 205-216
Li, Z.-C.; Li, H.-J.; Dai, L.-L.; Gao, Y.-Q.; Cai, W.-P.; Li, H.-Y.; Huang, X.-J.; Zhang, T.; Wu, H. 2010: Liver injury in HIV-1-infected patients receiving non-nucleosides reverse transcriptase inhibitors-based antiretroviral therapy Chinese Medical Journal 123(24): 3587-3590
Van Herrewege, Y.; Michiels, J.; Van Roey, J.; Fransen, K.; Kestens, L.; Balzarini, J.; Lewi, P.; Vanham, G.; Janssen, P. 2004: In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides Antimicrobial Agents and ChemoTherapy 48(1): 337-339
Funk, M.B.; Linde, R.; Wintergerst, U.; Notheis, G.; Hoffmann, F.; Schuster, T.; Kornhuber, B.; Ahrens, P.; Kreuz, W. 1999: Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children Aids 13(13): 1653-1658
Flandre, P.; Descamps, D.; Joly, V.; Meiffrédy, V.; Tamalet, C.; Izopet, J.; Aboulker, J-Pierre.; Brun-Vézinet, Fçoise. 2003: Predictive factors and selection of thymidine analogue mutations by nucleoside reverse transcriptase inhibitors according to initial regimen received Antiviral Therapy 8(1): 65-72